The neuronal insulin receptor in its environment

Journal of Neurochemistry

Volumn 140, Issue 3, 2017, Pages 359-367

  Gralle, Matthias ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Alzheimer's disease; dendritic spine; glycosylation; membrane domain; splicing; synaptic plasticity

Indexed keywords

CHOLESTEROL; DOPAMINE; INSULIN; INSULIN RECEPTOR; METABOTROPIC RECEPTOR; NEUROTRANSMITTER; NORADRENALIN; POSTSYNAPTIC RECEPTOR; SOMATOMEDIN C RECEPTOR; SPHINGOLIPID; TYROSINE KINASE RECEPTOR; INSR PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADIPOSE TISSUE; ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DEMENTIA; DENDRITIC SPINE; DOWNSTREAM PROCESSING; ENDOCYTOSIS; EXOCYTOSIS; GLYCOSYLATION; IMMUNOCYTOCHEMISTRY; INSULIN RESISTANCE; LIVER; NERVE CELL PLASTICITY; NONHUMAN; PANCREAS; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; REVIEW; SEQUENCE HOMOLOGY; SYMPTOMATOLOGY; SYNAPTIC TRANSMISSION; AGONISTS; ANIMAL; BRAIN; DRUG EFFECTS; HUMAN; METABOLISM; NERVE CELL; PHYSIOLOGY;

ALZHEIMER DISEASE; ANIMALS; ANTIGENS, CD; BRAIN; HUMANS; INSULIN; NEURONAL PLASTICITY; NEURONS; RECEPTOR, INSULIN;

EID: 85007454194     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13909     Document Type: Review

References (114)

1. Abbott M. A., Wells D. G. and Fallon J. R. (1999) The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses. J. Neurosci. 19, 7300–7308.
2. Ahmadian G., Ju W., Liu L. et al. (2004) Tyrosine phosphorylation of GluR2 is required for insulin-stimulated AMPA receptor endocytosis and LTD. EMBO J. 23, 1040–1050.
3. Alghamdi F., Guo M., Abdulkhalek S., Crawford N., Amith S. R. and Szewczuk M. R. (2014) A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes. Cell. Signal. 26, 1355–1368.
4. Ashpole N. M., Sanders J. E., Hodges E. L., Yan H. and Sonntag W. E. (2015) Growth hormone, insulin-like growth factor-1 and the aging brain. Exp. Gerontol. 68, 76–81.
5. Banks W. A., Jaspan J. B. and Kastin A. J. (1997) Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays. Peptides 18, 1257–1262.
6. Beattie E. C., Carroll R. C., Yu X., Morishita W., Yasuda H., von Zastrow M. and Malenka R. C. (2000) Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat. Neurosci. 3, 1291–1300.
7. Bedinger D. H. and Adams S. H. (2015) Metabolic, anabolic, and mitogenic insulin responses: a tissue-specific perspective for insulin receptor activators. Mol. Cell. Endocrinol. 415, 143–156.
8. Belfiore A., Frasca F., Pandini G., Sciacca L. and Vigneri R. (2009) Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr. Rev. 30, 586–623.
9. Bobsin K. and Kreienkamp H.-J. (2016) Severe learning deficits of IRSp53 mutant mice are caused by altered NMDA receptor dependent signal transduction. J. Neurochem. 136, 752–763.
10. Bogdanov Y., Michels G., Armstrong-Gold C., Haydon P. G., Lindstrom J., Pangalos M. and Moss S. J. (2006) Synaptic GABAA receptors are directly recruited from their extrasynaptic counterparts. EMBO J. 25, 4381–4389.
11. Bomfim T. R., Forny-Germano L., Sathler L. B. et al. (2012) An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease – associated Abeta oligomers. J. Clin. Invest. 122, 1339–1353.
12. Born J., Lange T., Kern W., McGregor G. P., Bickel U. and Fehm H. L. (2002) Sniffing neuropeptides: a transnasal approach to the human brain. Nat. Neurosci. 5, 514–516.
13. Boyd F. T., Clarke D. W., Muther T. F. and Raizada M. K. (1985) Insulin receptors and insulin modulation of norepinephrine uptake in neuronal cultures from rat brain. J. Biol. Chem. 260, 15880–15884.
14. Brennan W. J. (1988) Developmental aspects of the rat brain insulin receptor: loss of sialic acid and fluctuation in number characterize fetal development. Endocrinology 122, 2364–2370.
15. Bruning J. C., Gautam D., Burks D. J., Gillette J., Schubert M., Orban P. C., Klein R., Krone W., Muller-Wieland D. and Kahn C. R. (2000) Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122–2125.
16. Caraiscos V. B., Bonin R. P., Newell J. G., Czerwinska E., Macdonald J. F. and Orser B. A. (2007) Insulin increases the potency of glycine at ionotropic glycine receptors. Mol. Pharmacol. 71, 1277–1287.
17. Chiu S.-L. and Cline H. T. (2010) Insulin receptor signaling in the development of neuronal structure and function. Neural Dev. 5, 7–7.
18. Chiu S. L., Chen C. M. and Cline H. T. (2008) Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo. Neuron 58, 708–719.
19. Choi J., Ko J., Racz B. et al. (2005) Regulation of dendritic spine morphogenesis by insulin receptor substrate 53, a downstream effector of Rac1 and Cdc42 small GTPases. J. Neurosci. 25, 869–879.
20. Christie J. M., Wenthold R. J. and Monaghan D. T. (1999) Insulin causes a transient tyrosine phosphorylation of NR2A and NR2B NMDA receptor subunits in rat hippocampus. J. Neurochem. 72, 1523–1528.
21. Chung W., Choi S. Y., Lee E. et al. (2015) Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression. Nat. Neurosci. 18, 435–443.
22. Clarke D. W., Boyd F. T., Kappy M. S. and Raizada M. K. (1984) Insulin binds to specific receptors and stimulates 2-deoxy-d-glucose uptake in cultured glial cells from rat brain. J. Biol. Chem. 259, 11672–11675.
23. Claxton A., Baker L. D., Wilkinson C. W., Trittschuh E. H., Chapman D., Watson G. S., Cholerton B., Plymate S. R., Arbuckle M. and Craft S. (2013) Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. J. Alzheimers Dis. 35, 789–797.
24. Claxton A., Baker L. D., Hanson A., Trittschuh E. H., Cholerton B., Morgan A., Callaghan M., Arbuckle M., Behl C. and Craft S. (2015) Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. J. Alzheimers Dis. 44, 897–906.
25. Coba M. P., Munoz M. C., Dominici F. P., Toblli J. E., Pena C., Bartke A. and Turyn D. (2004) Increased in vivo phosphorylation of insulin receptor at serine 994 in the liver of obese insulin-resistant Zucker rats. J. Endocrinol. 182, 433–444.
26. Craft S., Baker L. D., Montine T. J. et al. (2012) Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment. Arch. Neurol. 69, 29–38.
27. De Felice F. G., Velasco P. T., Lambert M. P., Viola K., Fernandez S. J., Ferreira S. T. and Klein W. L. (2007) A-beta oligomers induce neuronal oxidative stress through an N-methyl-d-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J. Biol. Chem. 282, 11590–11601.
28. De Felice F. G., Vieira M. N. N., Bomfim T. R., Decker H., Velasco P. T., Lambert M. P., Viola K. L., Zhao W.-Q., Ferreira S. T. and Klein W. L. (2009) Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of A-beta oligomers. Proc. Natl Acad. Sci. USA 106, 1971–1976.
29. De Meyts P. (2015) Insulin/receptor binding: the last piece of the puzzle? BioEssays 37, 389–397.
30. Decker H., Jürgensen S., Adrover M. F., Brito-Moreira J., Bomfim T. R., Klein W. L., Epstein A. L., De Felice F. G., Jerusalinsky D. and Ferreira S. T. (2010) N-methyl-d-aspartate receptors are required for synaptic targeting of Alzheimer's toxic Abeta oligomers. J. Neurochem. 115, 1520–1529.
31. Dixon-Salazar T. J., Fourgeaud L., Tyler C. M., Poole J. R., Park J. J. and Boulanger L. M. (2014) MHC class I limits hippocampal synapse density by inhibiting neuronal insulin receptor signaling. J. Neurosci. 34, 11844–11856.
32. Dotti C. G., Esteban J. A. and Ledesma M. D. (2014) Lipid dynamics at dendritic spines. Front. Neuroanat. 8, 76.
33. Dou J. T., Chen M., Dufour F., Alkon D. L. and Zhao W. Q. (2005) Insulin receptor signaling in long-term memory consolidation following spatial learning. Learn. Mem. 12, 646–646.
34. Dridi L., Seyrantepe V., Fougerat A. et al. (2013) Positive regulation of insulin signaling by neuraminidase 1. Diabetes 62, 2338–2346.
35. Duarte A. I., Proença T., Oliveira C. R., Santos M. S. and Rego A. C. (2006) Insulin restores metabolic function in cultured cortical neurons subjected to oxidative stress. Diabetes 55, 2863–2870.
36. Ferreira S. T. and Klein W. L. (2011) The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease. Neurobiol. Learn. Mem. 96, 529–543.
37. García-De Lacoba M., Alarcón C., De La Rosa E. J. and De Pablo F. (1999) Insulin/insulin-like growth factor-I hybrid receptors with high affinity for insulin are developmentally regulated during neurogenesis. Endocrinology 140, 233–243.
38. Garwood C. J., Ratcliffe L. E., Morgan S. V., Simpson J. E., Owens H., Vazquez-Villaseñor I., Heath P. R., Romero I. A., Ince P. G. and Wharton S. B. (2015) Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors. Mol. Brain 8, 51–51.
39. Gejl M., Gjedde A., Egefjord L. et al. (2016) In Alzheimer's disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial. Front. Aging Neurosci. 8, 108.
40. Ghasemi R., Haeri A., Dargahi L., Mohamed Z. and Ahmadiani A. (2013) Insulin in the brain: sources, localization and functions. Mol. Neurobiol. 47, 145–171.
41. Gomes R. J., de Oliveira C. A., Ribeiro C., Mota C. S., Moura L. P., Tognoli L. M., Leme J. A., Luciano E. and de Mello M. A. (2009) Effects of exercise training on hippocampus concentrations of insulin and IGF-1 in diabetic rats. Hippocampus 19, 981–987.
42. Gray S. M., Meijer R. I. and Barrett E. J. (2014) Insulin regulates brain function, but how does it get there? Diabetes 63, 3992–3997.
43. Grillo C. A., Piroli G. G., Lawrence R. C. et al. (2015) Hippocampal insulin resistance impairs spatial learning and synaptic plasticity. Diabetes 64, 3927–3936.
44. Gupta A. and Dey C. S. (2012) PTEN, a widely known negative regulator of insulin/PI3K signaling, positively regulates neuronal insulin resistance. Mol. Biol. Cell 23, 3882–3898.
45. Haas L. T. and Strittmatter S. M. (2016) Oligomers of amyloid-beta prevent physiological activation of the cellular prion protein-metabotropic glutamate receptor 5 complex by glutamate in Alzheimer's Disease. J. Biol. Chem. 291, 17112–17121.
46. Harris A. Z. and Pettit D. L. (2007) Extrasynaptic and synaptic NMDA receptors form stable and uniform pools in rat hippocampal slices. J. Physiol. 584, 509–519.
47. Herzer S., Meldner S., Gröne H.-J. and Nordström V. (2015) Fasting-induced lipolysis and hypothalamic insulin signaling are regulated by neuronal glucosylceramide synthase. Diabetes 64, 3363–3376.
48. Heung M.-Y., Visegrady B., Fütterer K. and Machesky L. M. (2008) Identification of the insulin-responsive tyrosine phosphorylation sites on IRSp53. Eur. J. Cell Biol. 87, 699–708.
49. Hölscher C. (2014) First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease. Alzheimers Dement. 10, S33–S37.
50. Hori K., Yasuda H., Konno D., Maruoka H., Tsumoto T. and Sobue K. (2005) NMDA receptor-dependent synaptic translocation of insulin receptor substrate p53 via protein kinase C signaling. J. Neurosci. 25, 2670–2681.
51. Huang C. C., You J. L., Lee C. C. and Hsu K. S. (2003) Insulin induces a novel form of postsynaptic mossy fiber long-term depression in the hippocampus. Mol. Cell. Endocrinol. 24, 831–841.
52. Huang C.-C., Lee C.-C. and Hsu K.-S. (2004) An investigation into signal transduction mechanisms involved in insulin-induced long-term depression in the CA1 region of the hippocampus. J. Neurochem. 89, 217–231.
53. Huang L.-Y., Wang Y.-P., Wei B.-F. et al. (2013) Deficiency of IRTKS as an adaptor of insulin receptor leads to insulin resistance. Cell Res. 23, 1310–1321.
54. Hubbard S. R. (2013) The insulin receptor: both a prototypical and atypical receptor tyrosine kinase. Cold Spring Harb. Perspect. Biol. 5, 1–12.
55. Issad T., Tavaré J. M. and Denton R. M. (1991) Analysis of insulin receptor phosphorylation sites in intact rat liver cells by two-dimensional phosphopeptide mapping. Predominance of the tris-phosphorylated form of the kinase domain after stimulation by insulin. Biochem. J., 275(Pt 1), 15–21.
56. Jin Z., Jin Y., Kumar-Mendu S., Degerman E., Groop L. and Birnir B. (2011) Insulin reduces neuronal excitability by turning on GABA(A) channels that generate tonic current. PLoS ONE 6, e16188.
57. Joost H.-G. (1995) Structural and functional heterogeneity of insulin receptors. Cell. Signal. 7, 85–91.
58. Kabayama K., Sato T., Saito K., Loberto N., Prinetti A., Sonnino S., Kinjo M., Igarashi Y. and Inokuchi J. (2007) Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proc. Natl Acad. Sci. USA 104, 13678–13683.
59. Kappeler L., De Magalhaes Filho C., Dupont J., Leneuve P., Cervera P., Périn L., Loudes C. et al. (2008) Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism. PLoS Biol. 6, 2144–2153.
60. Kenner K. A., Kusari J. and Heidenreich K. A. (1995) cDNA sequence analysis of the human brain insulin receptor. Biochem. Biophys. Res. Commun. 217, 304–312.
61. Kim M.-H., Choi J., Yang J. et al. (2009) Enhanced NMDA receptor-mediated synaptic transmission, enhanced long-term potentiation, and impaired learning and memory in mice lacking IRSp53. J. Neurosci. 29, 1586–1595.
62. Kleinridders A., Ferris H. A., Cai W. and Kahn C. R. (2014) Insulin action in brain regulates systemic metabolism and brain function. Diabetes 63, 2232–2243.
63. Kleinridders A., Cai W., Cappellucci L., Ghazarian A., Collins W. R., Vienberg S. G., Pothos E. N. and Kahn C. R. (2015) Insulin resistance in brain alters dopamine turnover and causes behavioral disorders. Proc. Natl Acad. Sci. 112, 3463–3468.
64. Knudsen L., De Meyts P. and Kiselyov V. V. (2011) Insight into the molecular basis for the kinetic differences between the two insulin receptor isoforms. Biochem. J. 440, 397–403.
65. Könner A. C., Hess S., Tovar S., Mesaros A., Sánchez-Lasheras C., Evers N., Verhagen L. A. W. et al. (2011) Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis. Cell Metab. 13, 720–728.
66. Laurén J., Gimbel D. A., Nygaard H. B., Gilbert J. W. and Strittmatter S. M. (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers. Nature 457, 1128–1132.
67. Lee C. C., Huang C. C., Wu M. Y. and Hsu K. S. (2005) Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway. J. Biol. Chem. 280, 18543–18550.
68. Lee C. C., Huang C. C. and Hsu K. S. (2011) Insulin promotes dendritic spine and synapse formation by the PI3K/Akt/mTOR and Rac1 signaling pathways. Neuropharmacology 61, 867–879.
69. Leibiger B., Leibiger I. B., Moede T., Kemper S., Kulkarni R. N., Kahn C. R., De Vargas L. M. and Berggren P. O. (2001) Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells. Mol. Cell 7, 559–570.
70. Li G., Barrett E. J., Wang H., Chai W. and Liu Z. (2005) Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells. Endocrinology 146, 4690–4696.
71. Liu L., Brown J. C., Webster W. W., Morrisett R. A. and Monaghan D. T. (1995) Insulin potentiates N-methyl-d-aspartate receptor activity in Xenopus oocytes and rat hippocampus. Neurosci. Lett. 192, 5–8.
72. Long-Smith C. M., Manning S., McClean P. L., Coakley M. F., O'Halloran D. J., Holscher C. and O'Neill C. (2013) The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-β plaque and glial pathology in a mouse model of Alzheimer's disease. NeuroMolecular Med. 15, 102–114.
73. Lourenco M. V., Clarke J. R., Frozza R. L. et al. (2013) TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeys. Cell Metab. 18, 831–843.
74. Lowe W. L., Boyd F. T., Clarke D. W., Raizada M. K., Hart C. and LeRoith D. (1986) Development of brain insulin receptors: structural and functional studies of insulin receptors from whole brain and primary cell cultures. Endocrinology 119, 25–35.
75. Maesako M., Uemura K., Kuzuya A., Sasaki K., Asada M., Watanabe K., Ando K., Kubota M., Kihara T. and Kinoshita A. (2011) Presenilin regulates insulin signaling via a gamma-secretase-independent mechanism. J. Biol. Chem. 286, 25309–25316.
76. Man H. Y., Lin J. W., Ju W. H., Ahmadian G., Liu L., Becker L. E., Sheng M. and Wang Y. T. (2000) Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization. Neuron 25, 649–662.
77. Marks J. L., Maddison J. and Eastman C. J. (1988) Subcellular localization of rat brain insulin binding sites. J. Neurochem. 50, 774–781.
78. McElduff A., Poronnik P., Baxter R. and Williams P. (1988) A comparison of the insulin and insulin-like growth factor I receptors from rat brain and liver. Endocrinology 122, 1933–1939.
79. Molnár G., Faragó N., Kocsis Á. K. et al. (2014) GABAergic neurogliaform cells represent local sources of insulin in the cerebral cortex. J. Neurosci. 34, 1133–1137.
80. Morcavallo A., Genua M., Palummo A., Kletvikova E., Jiracek J., Brzozowski A. M., Iozzo R. V., Belfiore A. and Morrione A. (2012) Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform A. J. Biol. Chem. 287, 11422–11436.
81. Nair D., Hosy E., Petersen J. D., Constals A., Giannone G., Choquet D. and Sibarita J.-B. (2013) Super-resolution imaging reveals that AMPA receptors inside synapses are dynamically organized in nanodomains regulated by PSD95. J. Neurosci. 33, 13204–13224.
82. Nisticó R., Cavallucci V., Piccinin S. et al. (2012) Insulin receptor β-subunit haploinsufficiency impairs hippocampal late-phase ltp and recognition memory. NeuroMolecular Med. 14, 262–269.
83. Okamura-Oho Y., Miyashita T. and Yamada M. (2001) Distinctive tissue distribution and phosphorylation of IRSp53 isoforms. Biochem. Biophys. Res. Commun. 289, 957–960.
84. + channels. Neuropharmacology 44, 855–863.
85. Passafaro M., Piëch V. and Sheng M. (2001) Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons. Nat. Neurosci. 4, 917–926.
86. Pulford B. E. and Ishii D. N. (2001) Uptake of circulating insulin-like growth factors (IGFs) into cerebrospinal fluid appears to be independent of the IGF receptors as well as IGF-binding proteins. Endocrinology 142, 213–220.
87. Rajapaksha H. and Forbes B. E. (2015) Ligand-binding affinity at the insulin receptor isoform-A and subsequent IR-A tyrosine phosphorylation kinetics are important determinants of mitogenic biological outcomes. Front. Endocrinol. 6, 1–11.
88. Reger M. A., Watson G. S., Frey W. H. et al. (2006) Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol. Aging 27, 451–458.
89. Reger M. A., Watson G. S., Green P. S. et al. (2008) Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J. Alzheimers Dis. 13, 323–331.
90. Renner M., Lacor P. N., Velasco P. T., Xu J., Contractor A., Klein W. L. and Triller A. (2010) Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron 66, 739–754.
91. Sallam H. S., Tumurbaatar B., Zhang W.-R., Tuvdendorj D., Chandalia M., Tempia F., Laezza F., Taglialatela G. and Abate N. (2015) Peripheral adipose tissue insulin resistance alters lipid composition and function of hippocampal synapses. J. Neurochem. 133, 125–133.
92. Sauter A., Goldstein M., Engel J. and Ueta K. (1983) Effect of insulin on central catecholamines. Brain Res. 260, 330–333.
93. Sawallisch C., Berhörster K., Disanza A. et al. (2009) The insulin receptor substrate of 53 kDa (IRSp53) limits hippocampal synaptic plasticity. J. Biol. Chem. 284, 9225–9236.
94. Schubert M., Gautam D., Surjo D. et al. (2004) Role for neuronal insulin resistance in neurodegenerative diseases. Proc. Natl Acad. Sci. USA 101, 3100–3105.
95. Skeberdis V. A., Lan J., Zheng X., Zukin R. S. and Bennett M. V. (2001) Insulin promotes rapid delivery of N-methyl-d-aspartate receptors to the cell surface by exocytosis. Proc. Natl Acad. Sci. USA 98, 3561–3566.
96. Stanley M., Macauley S. L., Caesar E. E., Koscal L. J., Moritz W., Robinson G. O., Roh J., Keyser J., Jiang H. and Holtzman D. M. (2016) The effects of peripheral and central high insulin on brain insulin signaling and amyloid-beta in young and old APP/PS1 mice. J. Neurosci. 36, 11704–11715.
97. Stoeckel L. E., Arvanitakis Z., Gandy S., Small D., Kahn C. R., Pascual-Leone A., Pawlyk A., Sherwin R. and Smith P. (2016) Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction. F1000Res 5, 353.
98. Stöhr O., Schilbach K., Moll L. et al. (2013) Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's disease. Age (Dordr) 35, 83–101.
99. Taghibiglou C., Bradley C. A., Gaertner T., Li Y., Wang Y. and Wang Y. T. (2009) Mechanisms involved in cholesterol-induced neuronal insulin resistance. Neuropharmacology 57, 268–276.
100. Talbot K., Wang H., Kazi H. et al. (2012) Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Invest. 122, 1316–1338.
101. Tatulian S. A. (2015) Structural dynamics of insulin receptor and transmembrane signaling. Biochemistry 54, 5523–5532.
102. Townsend M., Mehta T. and Selkoe D. J. (2007) Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. J. Biol. Chem. 282, 33305–33312.
103. Uhles S., Moede T., Leibiger B., Berggren P.-O. and Leibiger I. B. (2003) Isoform-specific insulin receptor signaling involves different plasma membrane domains. J. Cell Biol. 163, 1327–1337.
104. Wan Q., Xiong Z. G., Man H. Y., Ackerley C. A., Braunton J., Lu W. Y., Becker L. E., MacDonald J. F. and Wang Y. T. (1997) Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin. Nature 388, 686–690.
105. Ward C. W., Menting J. G. and Lawrence M. C. (2013) The insulin receptor changes conformation in unforeseen ways on ligand binding: sharpening the picture of insulin receptor activation. BioEssays 35, 945–954.
106. Werner H., Raizada M. K., Mudd L. M., Foyt H. L., Simpson I. A., Roberts C. T. and LeRoith D. (1989) Regulation of rat brain/HepG2 glucose transporter gene expression by insulin and insulin-like growth factor I in primary cultures of neuronal and glial cells. Endocrinology 125, 314–320.
107. Weyhenmeyer J. A., Reiner A. M., Reynolds I. and Killian A. (1985) Light and electron microscopic analysis of insulin binding sites on neurons in dissociated brain cell cultures. Brain Res. Bull. 14, 415–421.
108. Yeh T. C., Ogawa W., Danielsen A. G. and Roth R. A. (1996) Characterization and cloning of a 58/53-kDa substrate of the insulin receptor tyrosine kinase. J. Biol. Chem. 271, 2921–2928.
109. Youngren J. F. (2007) Regulation of insulin receptor function. Cell. Mol. Life Sci. 64, 873–891.
110. Zhao W., Chen H., Xu H., Moore E., Meiri N., Quon M. J. and Alkon D. L. (1999) Brain insulin receptors and spatial memory. J. Biol. Chem. 274, 34893–34902.
111. Zhao W. Q., De Felice F. G., Fernandez S., Chen H., Lambert M. P., Quon M. J., Krafft G. A. and Klein W. L. (2008) Amyloid beta oligomers induce impairment of neuronal insulin receptors. FASEB J. 22, 246–260.
112. Zhao W. Q., Lacor P. N., Chen H., Lambert M. P., Quon M. J., Krafft G. A. and Klein W. L. (2009) Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric Aβ. J. Biol. Chem. 284, 18742–18753.
113. Zhao W.-Q., Santini F., Breese R. et al. (2010) Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption. J. Biol. Chem. 285, 7619–7632.
114. Zhou J., Jones D. R., Duong D. M., Levey A. I., Lah J. J. and Peng J. (2013) Proteomic analysis of postsynaptic density in Alzheimer's disease. Clin. Chim. Acta 420, 62–68.